Document is current
Any future updates will be listed below
-
Authors
Demirsoy, Emre
Parkin, Teagan I.
Mihalynuk, Shaeleen E.
Dema, Anna H.
Corrie, Lorissa
Heilker, Marika E.
Kuecks-Winger, Haley N.
Yanai, Anat
Birol, Uluc B.
McIlwee, Michael
de Wet, Kay
Knipscheer, Mathijs
Bowes, Victoria
Tuytel, Vanessa
Ritchie, Liam
Köster, Wolfgang
Berberov, Emil
Cox, William R.
Kotkoff, Monica
Thompson, Vanessa C.
Warren, René L.
Fraser, Erin
Hoang, Linda M. N.
Hof, Fraser
Birol, Fatih
Helbing, Caren C.
Birol, Inanc
-
Funding
Funding for this research was provided by:
Genome Canada (#291PEP)
Genome British Columbia (#291PEP)
Mitacs (IT28945 and IT43363)
Investment Agriculture Foundation of British Columbia (INV106 and INV247)
Amphoraxe Life Sciences Inc.
Chicken Farmers of Canada
Producteurs d'oeufs d'incubation du Canada
- License Information
-
More Information
Article History
Received: 8 November 2025
Accepted: 9 April 2026
First Online: 15 May 2026
Declarations
:
: All animal experiments were approved by the University of Saskatchewan and University of Victoria Animal Care Committees (Protocols #19940213 and AE-23-012, respectively) and conducted in accordance with the guidelines of the Canadian Council on Animal Care.
: Not applicable.
: Inanc Birol is a founder, Chief Scientific Officer, and equity holder of Amphoraxe Life Sciences Inc., which has licensed intellectual property related to antimicrobial peptides described in this manuscript. The following authors are named inventors on related intellectual property (IP): Caren C. Helbing, Erin Fraser, Fraser Hof, Lorissa Corrie, René L. Warren, Vanessa C. Thompson, Anat Yanai, Inanc Birol, and Linda M. N. Hoang. Monica Kotkoff is also a stakeholder on the IP. Emre Demirsoy, Teagan I. Parkin, and Anna H. Dema received internship funding from Amphoraxe through Mitacs. Amphoraxe contributed to aspects of the work, including study design for selected experiments, resource allocation, collaborative experimental activities, internship support, and participation in manuscript preparation. The authors retained control over data collection, analysis, interpretation, and the decision to submit the manuscript for publication. All other authors declare no competing interests.
